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Abstract
Background: Unitary pseudogenes are a class of unprocessed pseudogenes without functioning counterparts in
the genome. They constitute only a small fraction of annotated pseudogenes in the human genome. However, as
they represent distinct functional losses over time, they shed light on the unique features of humans in primate
evolution.
Results: We have developed a pipeline to detect human unitary pseudogenes through analyzing the global
inventory of orthologs between the human genome and its mammalian relatives. We focus on gene losses along
the human lineage after the divergence from rodents about 75 million years ago. In total, we identify 76 unitary
pseudogenes, including previously annotated ones, and many novel ones. By comparing each of these to its
functioning ortholog in other mammals, we can approximately date the creation of each unitary pseudogene (that
is, the gene ‘death date’) and show that for our group of 76, the functional genes appear to be disabled at a fairly
uniform rate throughout primate evolution - not all at once, correlated, for instance, with the ‘Alu burst’.
Furthermore, we identify 11 unitary pseudogenes that are polymorphic - that is, they have both nonfunctional and
functional alleles currently segregating in the human population. Comparing them with their orthologs in other
primates, we find that two of them are in fact pseudogenes in non-human primates, suggesting that they
represent cases of a gene being resurrected in the human lineage.
Conclusions: This analysis of unitary pseudogenes provides insights into the evolutionary constraints faced by
different organisms and the timescales of functional gene loss in humans.
Background
Pseudogenes (ψ) are nongenic DNA segments that exhi-
bit a high degree of sequence similarity to functional
genes but contain disruptive defects. The initial pseudo-
genization of a functional gene is most likely a single
mutagenic event that results in premature stop codons,
abolished splice junctions, shifts to the coding frame, or
impaired transcriptional regulatory sequences. Most
pseudogenes are disabled copies of a functional ‘parent’
gene and can be classified as either processed or dupli-
cated pseudogenes depending on whether they are gen-
erated by the retro-transposition of processed mRNA
transcripts or the duplication of gene-containing DNA
segments in the genome. Recently, the pseudogene
complement of the human genome has been investi-
gated both in gene family-specific studies [1-4] and in
comprehensive surveys [5-7]. Of the approximately
20,000 pseudogenes identified in early studies, most, if
not all, do not represent the extinction of a function as
their ‘parent’ genes are intact and functional.
A third group of pseudogenes particularly relevant to
functional analyses are unitary pseudogenes, which are
unprocessed pseudogenes with no functional counter-
parts. They are generated by disruptive mutations occur-
ring in functional genes and prevent them from being
successfully transcribed or translated. They differ from
duplicated pseudogenes in that the disabled gene had an
established function rather than being a more recent
copy of a functional gene. The initial analysis of the
e u c h r o m a t i cs e q u e n c eo ft h eh u m a ng e n o m ei d e n t i f i e d
37 unitary pseudogene candidates [8]. In addition to
* Correspondence: mark.gerstein@yale.edu
1Department of Molecular Biophysics and Biochemistry, Yale University, New
Haven, CT 06520, USA
Zhang et al. Genome Biology 2010, 11:R26
http://genomebiology.com/2010/11/3/R26
© 2010 Zhang et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.unitary pseudogenes with fixed disruptive nucleotide
substitutions, human genes with polymorphic disruptive
sites that are currently segregating in the human popu-
lation have also been indentified [8-10], and many of
them provide the genetic bases of certain inheritable
diseases [11]. Such gene deactivation, which happens in
situ giving rise to a unitary pseudogene, results in a loss
to the functional part of the genetic repertoire of the
organism. Polymorphic pseudogenes are unlikely to
become fixed in a population if the gene loss is deleter-
ious. However, various evolutionary processes, such as
genetic drift, migration (population bottleneck), and in
some cases, natural selection, can lead to fixation. A
number of genes are known to have been lost in the
human lineage in comparison with other mammals
[4,12-15].
In this study, we develop a novel comparative geno-
mic approach to identify genes disabled in situ without
af u n c t i o n a lc o p y( u n i t a r yp s e u d o g e n e s )u s i n gt h e
absence of human proteins orthologous to their mouse
counterparts as the signals of losses of well-established
genes. Our method is able to systematically detect the
sequence signature left by such genic losses, distin-
guishing true loss from mere loss of redundant genes
following duplication or retrotransposition. We identify
historic and contemporary losses of protein-coding
genes in the human lineage since the last common
ancestor of euarchontoglires (primates and rodents). In
addition to pseudogenes in tandem gene families, we
identify 76 losses of well-established genes in the
human lineage since the common ancestor with
mouse. Moreover, we also find 11 genes with poly-
morphic disruptive sites. This latter set represents
gene losses on a very different timescale: the genic and
pseudogenic alleles are segregating in the current
human population and are subject to various evolu-
tionary forces.
Results
Gene loss is indicated by the absence of orthologs
After a speciation event, the increasing divergence
between two resultant species reflects the diminution in
their genic orthology as gains and losses of genes gradu-
ally accumulate in each of them. Thus, the presence of
genes unique to one species relative to another indicates
either gene gains in one or gene losses in the other. In
common with many other genomic features, genes in all
species are in a state of flux during evolution. However,
since all species are related to one another through spe-
ciation, gains and losses of genes in one species can be
identified only relative to another. Based on this obser-
vation, we developed a pipeline that uses the ortholo-
gous relationship between genes from a pair of species
to detect gene losses in one of them.
To take advantage of rich genomic annotation avail-
able for mouse, our study uses the mouse gene set as
the reference to identify genes that have been lost in the
human lineage since the divergence of these two species.
Using the InParanoid [16] human-mouse orthologous
gene set, we find 6,236 mouse proteins without discern-
ible human orthologs. The presence of these unique
mouse proteins indicates, most likely, both gene gains in
the mouse lineage and gene losses in the human one.
There are 2,005 unique mouse proteins that cannot be
aligned to the human genome and thus are likely to be
gene gains in the mouse. For the remaining unique
mouse proteins that can be aligned, we found disrup-
tions to the putative human coding sequences in 974
sequence alignments. Subsequent removal of redun-
dancy reveals 612 potentially pseudogenic loci; 187 loci
are removed from the list because they are identified
based on predicted or modeled mouse genes, whose
validity cannot be easily verified; 94 loci are also
removed without further consideration as their identifi-
cations are based on unspliced mouse transcribed
sequences labeled as ‘expressed’ or ‘RIKEN cDNA’
sequences. The filtering steps leave 258 loci based on
annotated mouse genes and 73 of these are based on
spliced mouse ‘expressed’ or ‘RIKEN cDNA’ sequences.
Manual inspection of each of the remaining 331 pseudo-
genic loci removes 113 falsep o s i t i v e s( s u c ha so n e s
found in short, low-quality sequence alignments) and
confirms the presence of 228 disabled human genes,
which include 122 pseudogenes in large gene families,
81 possible fixed human unitary pseudogenes, and
15 likely segregating human pseudogenes. After remov-
ing five human fixed pseudogenes that are not in
regions syntenic to those of their mouse orthologs and
four segregating pseudogenes whose identifications are
attributed to the sequence errors in the human refer-
ence genome, we identify 87 unitary pseudogenes, of
which 76 are fixed and 11 still segregating in the human
population (Figure 1b).
Many genes were lost in the human lineage since the
human-mouse divergence
Using the human-mouse genic orthology, we identify
228 pseudogenic loci - about 1% of the human gene cat-
alog - in the human genome, which include 98 olfactory
receptors, 23 vomeronasal receptors, and 1 zinc finger
protein. The large number of olfactory receptors and
vomeronasal receptors found in our study is consistent
with previous observations [17,18]. These gene families
form tandem gene clusters and have experienced copy
number changes and complex local rearrangements.
Because the dynamics of gene clusters make it difficult
to unambiguously discern ortholog/paralog relationships
between species, it is difficult to discern the ‘unitary’
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zinc finger pseudogenes (Table S1 in Additional file 1)
and thus they are excluded from further analyses in this
study.
We found 76 gene losses in the human lineage since
the human-mouse divergence (Table 1; see Table S2 in
Additional file 1 for more information). Of these, 31 are
identified through uncharacterized mouse genes. Some
are previously identified human unitary pseudogenes,
such as pseudogenes of gulonolactone (L-) oxidase
(GULO), an enzyme that produces the precursor to vita-
min C [19], urate oxidase (UOX), an enzyme that cata-
lyzes the oxidation of uric acid to allantoin [15], and
Farnesoid × receptor beta, a nuclear receptor for lanos-
terol [4]. In addition, we also confirm the human-speci-
fic loss of cardiotrophin-2 (CTF2) due to a frameshift to
its coding sequence causedb ya n8 - b pd e l e t i o n[ 2 0 ] ,
and hyaluronoglucosaminidase 6 (HYAL6) with two fra-
meshift-causing deletions [21].
Most of the 76 gene losses occurred in gene families
with multiple members: of the 47 examples that are
orthologous to annotated mouse genes and whose syn-
teny with their mouse orthologs can be identified with
confidence; half of them are from gene families with
more than six members (Figure 2). There is, however,
no correlation between the size of gene families and the
number of unitary pseudogenes from them. At one
extreme, pseudogenes of GULO, major urinary protein
(MUP), nephrocan (NEPN), neurotrophin receptor asso-
ciated death domain (NRADD), threonine aldolase 1
(THA1), and UOX do not have any closely related para-
logs. These genes are particularly intriguing as there are
no alternatives with similar sequences and, as such, they
represent unequivocal losses of biological functions.
Below we examine NEPN and MUP in more detail as
two case studies.
In a recent study, Mochida et al. showed NEPN is a
secreted N-glycosylated protein inhibitor of transform-
ing growth factor-b signaling in mouse and also identi-
fied putative NEPN gene orthologs in pig, dog, rat, and
chicken [22]. The human ortholog was not found, and
its absence was postulated to be a missed identification
due to a lesser homology with its counterparts in other
mammals. As this study and a previous one [23] demon-
strate, however, despite the lack of a closely related
homolog in the human genome, NEPN is a pseudogene
not only in human but also in chimpanzee, gorilla, and
rhesus with a shared coding sequence (CDS) disruptive
mutation; thus, its inactivation occurred at least 30 mil-
lions of years ago, before the divergence between the
catarrhines and the New World monkeys.
Except for MUP [24], which is a unitary pseudogene
only in human, all other five genes - GULO, NEPN,
NRADD, THA1,a n dUOX - were inactivated at least
Figure 1 Method for identifying human unitary pseudogenes
in comparison to the mouse genome. (a) The overall
methodological flowchart. The number of entries in the input/
output data set used at certain steps is shown in parentheses. (b)
Detailed inspection and synteny check of the potential human
unitary pseudogenic loci. Entries in the initial set of pseudogenic
loci are removed based on various criteria at different steps. The
final result - the unitary pseudogenes and the polymorphic
pseudogenes in human - are listed in Tables 1 and 2. See the main
text for details. MGI, Mouse Genome Informatics. OR, olfactory
receptor; VR, vomeronasal receptor; ZF, zinc finger protein.
Zhang et al. Genome Biology 2010, 11:R26
http://genomebiology.com/2010/11/3/R26
Page 3 of 17Table 1 Human unitary pseudogenes
Human unitary pseudogene genomic
location
Mouse ortholog
symbol
Mouse gene name
chr12+:110821507-110823878 Adam1b a disintegrin and metallopeptidase domain 1b
chr8+:17371392-17373372 Adam26B a disintegrin and metallopeptidase domain 26B
chr8-:39450156-39489335 Adam3 a disintegrin and metallopeptidase domain 3 (cyritestin)
chr8+:39299218-39358412 Adam5 a disintegrin and metallopeptidase domain 5
chr9-:103136199-103141451 Acnat2 acyl-coenzyme A amino acid N-acyltransferase 2
chr18+:54814947-54887164 Acyl3 acyltransferase 3 [RIKEN cDNA 5330437I02 gene]
chr1+:92304452-92305907 Aytl1b acyltransferase like 1B
chr11+:71909632-71910345 Art2b ADP-ribosyltransferase 2b
chr2+:201166115-201364602 Aox3l1 aldehyde oxidase 3-like 1
chr16+:2351147-2415839 Abca17 ATP-binding cassette, sub-family A (ABC1), member 17
chr1-:51789487-51812353 Calr4 calreticulin 4
chr16-:30823174-30826438 Ctf2 cardiotrophin 2
chr4-:123871155-123872802 Cetn4 centrin 4
chr19-:46006279-46009136 Cyp2t4 cytochrome P450, family 2, subfamily t, polypeptide 4
chr2-:178665477-178677441 Cyct cytochrome c, testis
chr4-:68540001-68564082 Desc4 Desc4 [RIKEN cDNA 9930032O22 gene]
chr11-:67136888-67140266 Doc2 g double C2, gamma
chr9+:35423704-35439561 Feta Feta [RIKEN cDNA 4930417 M19 gene]
chr10-:114057930-114106344 Gucy2 g guanylate cyclase 2 g
chr8:27473706-27502505 Gulo gulonolactone (L-) oxidase
chr1-:226718541-226718916 Hist3 h2ba histone cluster 3, H2ba
chr7+:123241442-123256569 Hyal6 hyaluronoglucosaminidase 6
chr9-:114761447-114764366 Mup4 major urinary protein 4
chr10+:81670064-81672769 Mbl1 mannose binding lectin (A) 1
chr6+:118061593-118072916 Nepn nephrocan
chr3+:47028800-47029644 Nradd neurotrophin receptor associated death domain
chr1+:115181467-115195621 Nr1 h5 nuclear receptor subfamily 1, group H, member 5
chrX+:101400687-101403403 Prame preferentially expressed antigen in melanoma
chr1+:200404371-200425048 Ptprv protein tyrosine phosphatase, receptor type, V
chr5+:140786050-140870922 Pcdhgb8 protocadherin gamma subfamily B, 8
chr19+:53875091-53876096 Sec1 secretory blood group 1
chr20-:1696610-1708642 Sirpb3 Sirpb3 [RIKEN cDNA F830045P16 gene]
chr2+:20449670-20459798 Slc7a15 solute carrier family 7 (cationic amino acid transporter, y+ system),
member 15
chr4-:70692183-70714196 Sult1d1 sulfotransferase family 1D, member 1
chr7+:142844251-142845153 Tas2r134 taste receptor, type 2, member 134
chr17+:59285910-59292052 Tcam1 testicular cell adhesion molecule 1
chrX+:83901067-83903982 Tex16 testis expressed gene 16
chr14-:63882652-63893934 Tex21 testis expressed gene 21
chr8-:145268106-145414584 Tssk5 testis-specific serine kinase 5
chr17-:73756179-73757460 Tha1 threonine aldolase 1
chr1+:33704438-33707143 Tlr12 toll-like receptor 12
chr6:-132971083-132972109 Taar3 trace amine-associated receptor 3
chr6-:132957230-132958269 Taar4 trace amine-associated receptor 4
chr11+:3587708-3615320 Trpc2 transient receptor potential cation channel, subfamily C, member 2
chr4-:68314827-68322204 Tmprss11c transmembrane protease, serine 11c
chr16-:2829662-2831734 Tmprss8 transmembrane protease, serine 8 (intestinal)
chr1-:84603696-84623086 Uox urate oxidase
See Table S2 in Additional file 1 for the list of 29 human unitary pseudogenes identified using unannotated mouse gene transcripts.
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below). Our study shows that human MUP was inacti-
vated by a splice-junction mutation (GT to AT) located
at the splice donor site of its second intron (Figure 3).
This ORF-disrupting mutation in MUP is not seen in
any other mammals whose genome sequences are avail-
able for examination. Using complete (or nearly com-
plete) MUP gene sequences from human, chimpanzee,
orangutan, rhesus and marmoset, we reconstruct the
gene sequences at ancestral nodes in its primate phylo-
geny and calculate the KA/KS ratio along each lineage.
The KA/KS ratio ranges from 0.36 to 0.58 and averages
out to 0.54, an elevated value compared with 0.12, the
median KA/KS ratio of protein-coding genes between
human and mouse [25]. A recent study showed the
MUP protein in mice is a pheromone ligand that pro-
motes aggressive behaviors through its binding to the
Vmn2r putative pheromone receptors (V2Rs) of the
accessory olfactory neural pathway and, compared to
other mammals being examined, there is a co-expansion
of MUPs and V2Rs in mouse, rat, and opossum [24].
Our analysis shows all human V2Rs have been inacti-
vated, corroborating previous studies, which revealed
V2Rs are also lost in other primates [18,24]. Thus, the
Figure 2 The origin of human unitary pseudogenes in the paralogous gene sets. The human unitary pseudogenes with annotation from
orthologous mouse genes are assigned to human paralogous gene sets, whose names are shown in the middle. The number of human unitary
pseudogenes in each paralogous gene set and the number of members in each paralogous gene set are plotted as green and blue bars,
respectively. Five unitary pseudogenes with uninformative annotation are denoted with question marks. Unitary pseudogenes without close
paralogs are enclosed by dashed lines. The unitary pseudogenes from the tandem gene families are indicated by gray bars. Inset: box plot of the
number of human unitary pseudogenes in each paralogous gene set and the number of members in each paralogous gene set.
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erated nonsynonymous substitution rate in MUP of pri-
mates suggest it could be a direct result of the loss of
the V2Rs, its specific receptors.
Hydrolase-related activity and structure are enriched in
human unitary pseudogenes
Before pseudogenization, the protein products of these
human unitary pseudogenes played diverse molecular
functional roles in many different biological processes at
various cellular locations as seen in their mouse coun-
terparts. To determine whether there is an enrichment
of labels in any of these three aspects of annotation, we
test for Gene Ontology (GO) term association in the
functional mouse counterparts of the human unitary
pseudogenes on the GO hierarchy using Fisher’se x a c t
test. After correcting for multiple hypothesis tests to
control the false discovery rate, we found significant
enrichment of one biological process term, the integrin-
mediated signaling pathway, and six molecular function
terms, which are all specialized hydrolase activity (Figure
4a, b), among the mouse orthologs of the human unitary
pseudogenes. The annotation shows that if functional,
nine human unitary pseudogenes would encode for
endopeptidases. Further examination shows five of them
- transmembrane protease, serine 8 (intestinal) and 11,
and three unnamed RIKEN cDNA genes - have the ser-
ine-type endopeptidase activity, and the other four - a
disintegrin and metallopeptidase domain (ADAM) 1, 3,
5, and 26 - have the metalloendopeptidase activity. Pro-
tein domain analysis shows that two Pfam domains -
reprolysin family propeptide and reprolysin (M12B)
family zinc metalloprotease - are enriched in the human
unitary pseudogenes (Figure 4c). Both of them are
found in the ADAM unitary pseudogenes.
Compared with mouse, human has lost five testis-spe-
cific genes: testicular cell adhesion molecule 1
(TCAM1), testis expressed gene 16 (TEX16), testis
expressed gene 21 (TEX21), testis-specific serine kinase
5( TSSK5), and cytochrome c, testis (CYCT)[ 2 ] .T h e
losses of these testis-specific genes in the human lineage
may have affected the distinctive processes that occur in
Figure 3 The human-specific pseudogene of the major urinary protein. A G-to-A nucleotide substitution (with the reverse highlight) at the
donor site of the second intron (delineated by the underlined splicing sites) abolishes the ORF of the coding sequence. The sequence
conservation is clearly discernable from the multiple sequence alignment of polypeptide sequences translated from partial exonic sequences
upstream and downstream of the splicing junction of MUP from 24 species.
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ferentiated fertility between two lineages.
Gene loss has occurred throughout primate evolution
To estimate the time when functional genes were dis-
abled to give rise to the human unitary pseudogenes, we
identify the earliest shared ORF-disrupting mutations
between humans and other mammals on the mamma-
lian species tree. Very few pseudogenic mutations are
shared outside of the primate clade. The most recent
lineages where the occurrence of the pseudogenic muta-
tions in the 47 annotated human unitary pseudogenes
can generate their observed sharing pattern are illu-
strated on a primate phylogeny (Figure 5a). Such shared
mutations indicate the pseudogenization events hap-
pened at every stage during primate evolution: from the
human lineage alone to the last common ancestor of the
great apes, the Old World monkeys, the New World
monkeys, and the tarsiers.
One interesting case is the evolution of NR1H5 in pri-
mates. A previous study of the nuclear receptor pseudo-
g e n e s[ 4 ]h a ss h o w nt h a tNR1H5 i sap s e u d o g e n ei n
human, chimpanzee, and rhesus monkey with three (out
of 14 in total) disruptive mutations - one frame-shift
mutation and one splice-junction mutation in the very
early part of the gene structure and one nonsense muta-
tion at the end of the CDS - shared by these three pri-
mate species. In the same study, based on sequences
from human, mouse, rat, and chicken, the silencing of
NR1H5 was dated to be approximately 42 million years
ago (MYA), which was slightly later than 42.9 MYA, the
estimated time of divergence between the catarrhines
and the New World monkeys [27]. However, because of
the uncertainties in the estimates of both dates (for
example, the 95% credibility interval of the divergence
time estimation is from 36.1 to 51.1 MYA), it is not
conclusive that the pseudogenization of NR1H5
occurred after the divergence between the catarrhines
Figure 4 Enrichment of Gene Ontology terms and Pfam domains in the human unitary pseudogene. Enriched GO terms and their
positions in the hierarchy of (a) biological process and (b) molecular function terms. Yellow nodes correspond to significant GO terms. (c) P-
values for significant GO terms and Pfam domains.
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identify NR1H5 in the recently published genomic
sequences of marmoset, a New World monkey, and
determine whether it contains any of the three pseudo-
genic mutations common to human, chimpanzee, and
rhesus. Despite the fact that only the first one-third of
the NR1H5 CDS can be found in marmoset due to the
incompleteness of its genome assembly, the two impor-
tant common disruptive mutations, whose positions are
covered by the partial sequence identification, are
absent. This finding suggests that the pseudogenization
of NR1H5 in the human lineage occurred indeed after
the divergence between the catarrhines and the New
World monkeys.
Using current genome sequences of human, chimpan-
zee, gorilla, orangutan, rhesus, marmoset, and tarsier,
we identify 11 genes - ADAM3, CTF2, HIST3H2BA,
MBL1, MUP, TMPRSS8, ADAM1B, ADAM5, DOC2G,
HYAL6,a n dTAS2R134 - with human-specific CDS dis-
ruptions, which occurred after the divergence of humans
and chimpanzees. Based on our sequence analysis, how-
ever, we find the last five of them - ADAM1B, ADAM5,
DOC2G, HYAL6,a n dTAS2R134 - are possibly also dis-
abled in other primates with disruptions at different
sites. Under the assumption that the neutral mutation
rate has remained constant since the human-chimpan-
zee divergence at 6.6 MYA, we estimate the time in the
hominid ancestor when the human-specific inactivation
mutations appeared in the aforementioned 11 genes.
The inactivation time of eight genes can be meaningfully
calculated, and the estimates are plotted along the time-
line from 6.6 MYA, when human and chimpanzee
diverged, to the present (Figure 5b; Table S3 in Addi-
tional file 1). None of unitary pseudogenes seems to be
Figure 5 Dating the pseudogenization events. (a) Timing of the disruptive mutations that gave rise to human unitary pseudogenes by
analyzing shared mutations. Only pseudogenes with annotations from orthologous mouse genes are shown. Ones without close paralogs are
underlined. (b) Timing of several pseudogenization events that occurred in the human lineage after the human-chimp divergence. See Table S3
in Additional file 1 for the estimates and their standard errors. LCA, last common ancestor.
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coding sequence of an ancestral functional gene. As the
plot shows, unlike Alu sequences, which had an excep-
tional surge of activity around 40 MYA [28], the pseu-
dogenization events occurred in a temporally random
fashion - that is, there is no burst of gene losses during
the human evolution since the human-chimpanzee
divergence. This difference in their age distributions
reflects the difference in underlying generative
mechanisms.
Some genes contain polymorphic disruptive sites and are
segregating in the human population
Some of the pseudogenic loci are transcribed and, con-
trary to the genomic sequence, their mRNA transcript
sequences lack the disruptive sites, suggesting they are
functional genes. Such discrepancy potentially indicates
the existence of polymorphic disruptive sites in those
g e n e sa st h eg e n o m i cD N Aa n dt h em R N Aw e r e
obtained and sequenced from different individuals. After
careful examination of both the genomic and the tran-
script sequences to ascertain their validity, we identified
11 human genes with polymorphic disruptive sites
(Table 2). Such genes are extreme cases of genetic poly-
morphisms, as they have a nonfunctional pseudogenic
allele segregating in the human population. Eight dis-
ruptive sites - four nonsense mutations and four 1-bp
indels - have been catalogued in dbSNP. Three of them,
all nonsense mutations, were included and typed in the
HapMap Project [29], and the other five sites are near
HapMap SNPs with a physical distance ranging from
20 bp to 1.7 kb (Table 2).
Various genomic and genetic features of the HapMap
SNPs rs17097921, rs4940595, and rs2842899 are sum-
marized in Table 3 (see Table S4 in Additional file 1 for
allele frequency information). Each of the nonsense
alleles should effectively pseudogenize the gene, as all
three SNPs are located in the early part of the coding
sequences. Using the HapMap genotype data, several
recent studies [30,31] scanned the human genome to
detect positive selection in human populations. These
t h r e eS N P sw e r en o tf o u n dt ob eu n d e rr e c e n tp o s i t i v e
selection. Such negative results, however, could be
caused by a lack of detection power due to a deficiency
in data and/or method. The human reference alleles of
all three SNPs are pseudogenic. The reference alleles in
other primates are functional for rs17097921 but pseu-
dogenic for both rs4940595 and rs2842899. Using the
genotype and allele frequency data from the HapMap
Project, we check for the Hardy-Weinberg equilibrium
for the two alleles of each SNP in each population and
all populations combined. Our statistical analysis shows
that, in the meta-population, the two alleles, T/G, of
rs4940595 are not at Hardy-Weinberg equilibrium (c
2
goodness-of-fit test, degrees of freedom = 2, c
2 = 8.659,
P =0 . 0 1 3 ) .W ec a l c u l a t eFST between two populations
to measure their difference (distance), and the FST
metric shows population subdivision in the meta-popu-
lation. Hierarchical clustering groups 11 populations
into two subdivisions: one composed of the Europeans
in Utah, the Tuscans in Italy, and the Gujarati Indians
in Houston, Texas, and the other the rest (Figure 6a).
The FST between these two subdivisions is 0.044, which
is highly significant based on the permutation test
Table 2 Human polymorphic pseudogenes
Gene CDS disruptive mutation dbSNP ID
c HapMap SNP ID
Change
a Location
b
Nonsense mutation
FBXL21 taT (Y) ® taA chr5+:135,300,350 rs17169429 (+27) rs17169429 (+27)
FCGR2C Cag (Q) ® Tag chr1+:159,826,011 rs3933769 (-60) rs3933769 (-60)
GPR33 Cga (R) ® Tga chr14-:31,022,505 rs17097921 rs17097921
SEC22B Caa (Q) ® Taa chr1+:143,815,304 rs2794062 rs16826061 (+95)
SERPINB11 Gaa (E) ® Taa chr18+:59,530,818 rs4940595 rs4940595
TAAR9 Aaa (K) ® Taa chr6+:132,901,302 rs2842899 rs2842899
Frame-shift mutation
CASP12 ΔCA chr11-:104,268,394-5 rs497116 (-67) rs497116 (-67)
KRTAP7-1 ΔT chr21-:31123841 rs35359062 rs9982775 (-20)
PSAPL1 ∇A chr4-:7,487,457 rs58463471 rs4484302 (+441)
TMEM158 ∇A chr3-:45,242,396 rs11402022 rs33751 (+725)
TPSB2 ΔC chr16-:1,219,240 rs2234647 rs2745145 (-1771)
aBase change, deletion, and insertion are denoted by ‘®’, ‘∇’,a n d‘Δ’ respectively.
bThe genomic location, based on the NCBI build 36 of the Human Reference
Genome, includes the chromosome, the strand (’+’ being forward and ‘-’ reverse), and the coordinate of the base change.
cThe identifier of the mutation as in
the dbSNP (build 129). If a mutation is not included in the dbSNP, the identifier of the closest SNP and its distance (shown in parentheses) to the mutation are
shown instead.
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Page 9 of 17(Figure 6b). Such population structure at rs4940595 -
the difference in the allelic frequencies in different
populations - could be the result, and thus a sign, of dif-
ferent selective regimes that the same allele at rs4940595
is subjected to in different population subdivisions.
Discussion
The pseudogene complement of the human genome has
been comprehensively surveyed in several early studies
[5-7]. Using sequence similarity between the proteome
and the (translated) genome as the signature, these stu-
dies found pseudogenic copies of functional genes that
were generated after duplication or retrotransposition in
the human genome. Such duplicated or processed pseu-
dogenes are probably of little evolutionary significance,
as the former are disabled soon after duplication and
the latter ‘dead on arrival’ [32]. In this study, however,
we systematically identify human unitary pseudogenes, a
class of pseudogenes that are especially interesting as it
is the functional genes themselves, not their genomic
copies generated by duplication or retrotransposition,
that have been disabled. Some human unitary pseudo-
genes have been identified on an individual basis when a
particular gene or gene family was studied (see the
references in Table S2 in Additional file 1). Using a
comparative genomic approach, Zhu et al.[ 2 3 ]i d e n t i -
fied 26 losses of well-established genes in the human
genome that were all lost at least 50 MYA after their
birth. We compared our and their sets and found that
in spite of using different methodological approaches,
both studies had in common many gene losses in the
human genome (Table S5 in Additional file 1).
To identify unitary pseudogenes in one species, we
need a reference gene set from another species. This is
not a mere operational convenience or necessity: unitary
pseudogenes are conceptually comparative entities as
speciation and gene duplication (and the possible subse-
quent gene death) are two separate events that most
likely happen at different times. As a result, different
sets of unitary pseudogenes in a species could be
identified if reference gene sets from several species are
used. For example, to identify human unitary pseudo-
genes, we can use mouse or chimpanzee gene sets.
When the human gene loss happened after the human-
chimp divergence and if the mouse and the chimp
orthologs are both conserved, we have the same identifi-
able unitary pseudogene in human corresponding to its
mouse or chimp ortholog (Figure 7a). If, however, the
gene loss happened between the human-mouse and the
human-chimp divergences and the mouse ortholog is
conserved, the human unitary pseudogene is only mean-
ingful and identifiable when the mouse gene set is used
for the comparison (Figure 7b). In a slightly more com-
plicated evolutionary scenario, if a gene was duplicated
after the human-mouse divergence and its copy was
successfully neo-functionalized (with substantial
sequence change) before the human-chimp divergence
and pseudogenized afterwards in the human lineage, the
human unitary pseudogene is relative to, and identifiable
by, its chimp ortholog (Figure 7c). Under this scenario,
such human unitary pseudogenes - including human
ψMYH16 - cannot be identified using the mouse pro-
tein/gene set and thus will be false negatives of the iden-
tification result (Table S6 in Additional file 1). The
comparison between the human and chimpanzee geno-
mic sequences has revealed a number of gene disrup-
tions in humans [33].
Within a population, the pseudogenization of a gene
does not happen instantaneously. Rather, after a disrup-
tive mutation occurs, the alleles at the locus undergo a
fixation process. Depending on the outcome, such a
mutation is either fixed or lost. Thus, every gene loss
goes through two stages: a polymorphic stage in the
contemporary population subject to evolutionary forces;
and a fixed stage freed from selective pressure. The
fixed mutation becomes the base substitution in the spe-
cies under study relative to the other and is identified
through comparison of the genomes of two species. By
comparing the human and the mouse genomes, we
identify 76 fixed unitary pseudogenes. In addition, we
Table 3 Polymorphic pseudogenes with the disruptive sites typed in the HapMap Project
a
CDS disrupted gene GPR33 SERPINB11 TAAR9
Disruptive mutation
b Cga (R) ® Tga Gaa (E) ® Taa Aaa (K) ® Taa
dbSNP ID rs17097921 rs4940595 rs2842899
Genomic location chr14-:31,022,505 chr18+:59,530,818 chr6+:132,901,302
Disrupted codon position
c 140 (332) 89 (388) 61 (344)
Reference allele in human T T T
Reference allele in other primates
d CT T
Test statistic for HWE in the meta-population
e 0.285 (P = 0.867) 8.659 (P = 0.013) 0.071 (P = 0.965)
aSee Table S4 in Additional file 1 for allele frequency information.
bBoth codons before and after the mutation (®) are shown with the affected base capitalized.
The amino acid residue encoded by the codon is given in parentheses.
cThe disrupted codon position in the coding sequence (CDS). The number of codons in
the CDS is given in parentheses.
dWidely regarded as the ancestral allele. Other primates currently include chimp, orangutan, and macaque.
eThe c
2 goodness-of-
fit test is used to test for the Hardy-Weinberg equilibrium (HWE) in the meta-population using the pooled genotype and allele frequency data.
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Page 10 of 17Figure 6 Population structure analysis for SNP rs4940595. (a) Hierarchical clustering of 11 populations using the FST metric. Two
subdivisions in the meta-population, as indicated by the dashed line, are clearly visible in the cluster. (b) Histogram of FST from the permutation
test using the population subdivisions as seen in (a).
Zhang et al. Genome Biology 2010, 11:R26
http://genomebiology.com/2010/11/3/R26
Page 11 of 17identify 11 human genes with pseudogenic alleles, whose
disruptive mutations include nonsense mutations and
frameshifts. Our identification of polymorphic pseudo-
g e n e si sb yn om e a n sc o m p r e h e n s i v ea sw es e a r c hi n
the reference genome sequence for only the loci that are
associated with both CDS disruptions and functional
mRNA sequences. To obtain a comprehensive set of
polymorphic pseudogenes, one approach would be to
map variation sites in dbSNP to the reference genome
and identify variations that can disrupt the ORF of
known genes.
Being at a relatively early stage of pseudogenization,
polymorphic pseudogenes in a population are subject to
various evolutionary forces depending on the function
of the normal alleles and the interaction between differ-
ent genotypes and the environment. Since the loss of a
s i n g l e - c o p yg e n ei so f t e nd e l e t e r i o u sa n du n l i k e l yt ob e
fixed in a population [34], it remains unclear under
what circumstances genes were silenced and how the
losses were tolerated and fixed in the ancestral
population. It has been proposed that, under certain
conditions, a gene could become disposable to the fit-
ness of the organism if the function that it provides
becomes redundant. When this happens, the pseudo-
genic allele could be fixed in the population by random
g e n e t i cd r i f tb e c a u s et h el o s so ft h eg e n ep r o d u c td i d
not constitute a disadvantage and, thus, there is little
selection against the gene loss. This release from selec-
tive pressure is believed to be how the nonfunctionaliza-
tion of L-gulono-g-lactone oxidase gene could be fixed
in humans and guinea pigs [13]: it has been hypothe-
sized that the guinea pig and human ancestors subsisted
on a naturally ascorbic acid-rich diet; therefore, the loss
of the enzyme did not constitute a disadvantage.
O nt h eo t h e rh a n d ,a sa r g u e db yt h e‘less is more’
hypothesis, gene loss may serve as an engine of evolu-
tionary change [35]. Instead of being a neutral event,
the silencing of a gene could be advantageous to the
organism and consequently sweep through the popula-
tion to fixation - the kind of adaptive evolution
Figure 7 Unitary pseudogene relativity. Given the phylogeny of human, chimpanzee, and mouse, a human unitary pseudogenes can arise
from a gene loss that occurred in different lineages, including: (a) the human lineage after the human-chimp divergence; (b) the human-
ancestral lineage after the human-mouse divergence but before the human-chimp divergence; and under different circumstances, such as (c)
loss of a subfunctionalized gene in the human lineage after a duplication event before the human-chimp divergence. Because the absence of a
functional gene in a species is only identifiable through the comparison with another species that has the functional ortholog, the human
unitary pseudogene can be identified in (a) by comparing the human gene set to either the chimp or the mouse set as both of them have the
human ortholog. In (b, c), however, the human unitary pseudogene can only be identified by comparing the human gene set to one of either
the mouse or chimp gene set, as the other one does not have the human ortholog given the evolutionary history of the gene under
consideration.
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Page 12 of 17illustrated by the inactivation of the a-1,3-galactosyl-
transferase gene in catarrhines [36], the CMP-N-acetyl-
neuraminic acid hydroxylase gene [12], the olfactory
receptor genes [17], and the sarcomeric myosin gene
[14] in humans as there seems to be a correlation
between pseudogenization and physiological/anatomic
changes. In addition to these fixed unitary pseudogenes,
studies have also shown that some null alleles confer a
selective advantage for the polymorphic pseudogenes in
the human population. For example, the chemokine
receptor CCR5 gene in human has a pseudogenic allele
with a 32-bp deletion. Homozygotes of this null allele
are strongly protected from infection by various patho-
gens, including HIV, and heterozygotes receive some
protection [9]. Another example is the caspase-12 gene.
It has been shown that carriers of the caspase-12 pseu-
dogene are more resistant to severe sepsis [37], and the
null allele has spread through most of the human popu-
lation within the past 100,000 years because of positive
selection [38].
There are 6,236 Mouse Genome Informatics (MGI)
mouse proteins and 6,020 Ensembl human proteins out-
side of the InParanoid-assigned human-mouse ortho-
logs. Such an absence of orthology is a result of both
gene deaths that generated unitary pseudogenes and
gene births that gave rise to novel genes in both species.
Using the absence of orthologs of mouse proteins in
human as the signal, we identify 76 such losses of well-
established genes in the human genome. Of the 2,005
human proteins that have no mouse orthologs and can-
not be mapped to the mouse reference genome, 638
passed the quality control and thus are included in the
current Ensembl release of the human protein set.
Because they cannot be mapped to the genome of dog,
the closest out-group of the human-mouse lineage with
the best genomic sequences, we believe the reason for
their lack of mouse orthologs is that they are novel
human genes, not that their mouse orthologs have been
deleted. If we take the 15,885 human-mouse orthologs
assigned by InParanoid as the set of genes before the
divergence between human and mouse, the unitary
pseudogenes and the novel genes generated in the
human lineage since the last common ancestor of
euarchontoglires, approximately 75 MYA, represent,
respectively, a loss and a gain of approximately 0.5% and
4% of the number of ancestral genes. Despite aforemen-
tioned examples of gene losses under positive selection,
this striking skew toward gene birth indicates strongly
that gene births are a more significant force for evolu-
tionary change than gene losses. It also confirms the
notion that as they represent functional losses to a spe-
cies, unitary pseudogenes are expected to be rare.
The reference allele in other primates - which is
widely taken as the ancestral state - of a human SNP
can shed light on its emergence and evolution. The
human reference alleles of three disruptive HapMap
SNPs (Table 3) are pseudogenic, which cannot be other-
wise given the method that we use to identify the poly-
morphic pseudogenes. As expected (Figure 8a), the
reference allele of one SNP in non-human primates is
functional. It is surprising, however, to find that the
reference alleles of two of the SNPs in non-human pri-
mates are pseudogenic. One explanation is that these
two loci in the common ancestor of human, chimp,
orangutan, and macaque were also polymorphic and
have been so in the descendent populations ever since
(Figure 8b). If their pseudogenic alleles have risen to
high frequencies in chimp, orangutan, and macaque, it
is possible for these two loci to be typed as pseudogenic
homozygotes (that is, the reference alleles) in all these
three non-human primate populations. Polymorphisms
at some HLA (human leukocyte antigen) loci are known
examples of polymorphisms that have crossed speciation
events, as these HLA loci are polymorphic in both
human and chimp. This explanation, however, requires
the polymorphisms at rs4940595 and rs2842899 to be
very ancient, at least 30 million years old. Another
explanation is that the pseudogenic alleles are indeed
fixed in chimp, orangutan, macaque, and the last com-
mon ancestor between them and human, but the genes
have been resurrected from the pseudogenic state in the
human lineage (Figure 8c). This seemingly implausible
resurrection event is believed to have happened to the
human IRGM gene through a series of complex struc-
tural events after it became pseudogenized in the
anthropoid common ancestor [39].
Conclusions
Unitary pseudogenes are unprocessed pseudogenes with
no functional counterparts. With complete genome
sequences of model organisms, we have developed a
novel method to detect such pseudogenes in a genome
through analyzing the global inventory of orthologs
between two organisms. Using this approach with very
conservative cutoffs to look for gene losses along the
human lineage after its divergence from rodents
approximately 75 MYA, we identify 76 unitary pseudo-
genes in the human genome. As relics of genes, they
shed particular light on the unique features of the
human genome during evolution. By comparing ortholo-
gous sequences, we assign ages to primate unitary pseu-
d o g e n e s ,a n df i n dt h a tt h ef o r m e rf u n c t i o n a lg e n e s
appear to have been disabled at a fairly uniform rate
throughout primate evolution and not in a sudden
burst. Furthermore, we find 11 polymorphic pseudo-
genes that have nonfunctional pseudogenic alleles cur-
rently segregating in the human population Comparing
them with their orthologs in other primates, we find
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mates, suggesting that these actually represent cases of a
gene that is in the process of being resurrected in the
human lineage. Identification and analysis of human
unitary pseudogenes afford unique insights into the evo-
lution and dynamics of the human genic repertoire and
the human genome at large.
Materials and methods
Identification of human unitary pseudogenes
The overall strategy of our approach is depicted in Fig-
ure 1a. To discover human unitary pseudogenes, we use
mouse proteins as the reference. Because by definition a
unitary pseudogene and a functional ortholog in a gen-
ome are mutually exclusive for a specific gene in
another genome, we first identify mouse proteins that
do not have human orthologs. To find such mouse pro-
teins, we use the InParanoid human-mouse ortholog set
(version 6.1, based on human Ensembl 43 and mouse
MGI 12 December 2006 protein sets). InParanoid is
used because it balances the false negative and false
positive rates and was top-ranked as an orthology tool
[40,41]. These mouse proteins are then mapped to the
human reference genome (Hsap NCBI build 36.1, hg18)
using BLAT [42] with its default parameters. If the best
mapping of a mouse protein to the human genome
gives a gene structure similar to that of the mouse gene,
the mapped human genomic region is extracted and
examined for disruptions (nonsense mutations and fra-
meshifts) to the coding sequence using GeneWise [43].
Some of the initially discovered human pseudogenes are
redundant as they could be identified by more than one
mouse gene due to duplicated gene annotations or high
sequence similarities among members of certain protein
families. The redundancy is removed by clustering the
initial set of pseudogenic candidates into pseudogenic loci
based on the overlap among their genomic coordinates.
These loci are grouped into four sets based on the annota-
tion of the mouse proteins expressed from: named genes;
cDNA/expressed sequences with introns; cDNA/expressed
sequences without introns; and modeled/predicted genes.
Given the low possibility for unitary pseudogenes to be
intronless and the difficulty to assess the reliability of the
modeled or predicted genes, the loci in the last two sets
are excluded from further consideration.
Loci in the first two sets are carefully examined to
ascertain their pseudogene status. Prior to manual anno-
tation, all genomic sequences are sent to an automated
analysis pipeline for similarity searches and ab initio
gene predictions. The searches are run on a computer
Figure 8 Polymorphic pseudogenes in human populations. (a) Human-specific pseudogenic polymorphism generated by gene inactivation.
(b) Pseudogenic polymorphism since the last common ancestor. (c) Human-specific pseudogenic polymorphism generated by pseudogene
resurrection.
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the Ensembl analysis pipeline system [44] and the
results displayed in the Zmap genome viewer. Addi-
tional external predictions and annotation can be visua-
lized in Zmap via a distributed annotation system
(DAS). The otterlace annotation interface allows the
user to build genes and edit annotations based on
homology to aligned mRNA, expressed sequence tag
and protein evidence by adding transcripts, exon coordi-
nates, CDSs, gene names and descriptions, remarks and
polyadenylation signals and sites [45].
All predicted unitary pseudogene loci are checked to
ensure the validity of the orthologous mouse protein-cod-
ing gene, to verify the conservation of synteny between the
human and mouse loci, and to confirm the pseudogenicity
of the human locus. Mouse loci identified as orthologs to
putative human unitary pseudogenes are fully manually
annotated; that is, the complete gene structures and CDSs
of all alternative splice variants are elucidated to confirm
both the coding potential of the locus and the accuracy of
the MGI annotated CDSs. Mouse loci identified as lacking
a CDS are rejected as unitary pseudogenes. Conservation
of synteny between mouse and human orthologs is estab-
lished by the identification of conserved flanking loci in
both the Zmap viewer and Ensembl MultiContig View.
Where the position of the putative orthologs is not con-
served, the human locus is rejected as a unitary pseudo-
gene. Finally, the putative human unitary pseudogene
locus is fully manually annotated. Loci are confirmed as
unitary pseudogenes where the alignment of the ortholo-
gous mouse protein sequence indicates a CDS disruption
(premature stop, frame-shift or truncation) fixed in the
human genome.
We also identify several cases where the ORF of a
gene is disrupted in the human reference genome
sequence but locus-specific transcripts lack the disrupt-
ing mutation. Such a contradiction may be a result of
polymorphism in the human population, as the genomic
DNA and the mRNA were obtained from different indi-
viduals. However, in some cases an apparent error in
the genomic sequence appears responsible. To identify
and remove false positives, we check the validity of the
base call under consideration in the human reference
genome by examining the sequences of the reads in the
trace archive. We confirm the transcript sequence by
multiple independent copies available in GenBank. All
errors in the genome sequence were reported to the
Genome Reference Consortium.
Identification of orthologous genic or pseudogenic
sequences in 43 species
We examine 44 vertebrates for genic or pseudogenic
sequences orthologous and syntenic to human unitary
pseudogenes. The organism, release version and time of
the genomic sequence download from the Ensembl
database are listed in Table S7 in Additional file 1.
To identify orthologous and syntenic sequences, we
first use the Fetch Alignments tool of Galaxy [46] to
extract ‘stitched’ blocks of the alignment of the above 44
genomic sequences for each of the 76 human unitary
pseudogenes in the human genome. Using the global
multiple sequence alignment ensures the orthology and
the synteny of mapped genomic sequences among spe-
cies. The sequences in the alignment blocks are then
mapped back using BLAT to their corresponding gen-
omes to recover any sequences not included in the
alignments. The subsequences corresponding to the 76
human unitary pseudogenes in the 44 genomes are
extracted from the start minus 5 kb and the end plus 5
kb of the BLAT alignments. The mouse protein
sequences are then aligned to the corresponding geno-
m i cs u b s e q u e n c e su s i n gG e n e W i s et oi d e n t i f yt h e i r
orthologs in the 44 genomes.
Functional and structural analyses of human unitary
pseudogenes
For functional and structural analyses, we search for GO
terms and Pfam domains that are over-represented
within the human unitary pseudogenes. Because pseudo-
genes are nonfunctional and thus not included in the
human gene annotation set, such analyses cannot be
performed directly. To circumvent this problem, we use
the 76 mouse functional orthologs of human unitary
pseudogenes as their proxies. To perform the analyses,
we combine all human genes and the 76 mouse genes
into one gene list and retrieve their GO and Pfam anno-
tations from Ensembl. BiNGO [47] is used to test the 76
mouse genes in comparison with the combined gene list
for GO term association on the GO hierarchy. We also
test for over-representation of Pfam domains using the
standard hypergeometric test with subsequent false dis-
covery rate correction for multiple hypotheses testing.
Estimation of the nonfunctionalization time of a human-
specific unitary pseudogene
To estimate the nonfunctionalization time (TN) of a uni-
tary pseudogene, we use the method devised by Chou
et al. [12]. It assumes that non-synonymous mutations
are selected against until the gene is inactivated; there-
after, mutations at both synonymous and non-synon-
ymous sites accumulate at the neutral mutation rate.
Sequences orthologous to the human pseudogene from
mouse and rat (and other organisms if available) are
used in the calculation, as the quantification of lineage-
specific mutation rates at synonymous and non-synon-
ymous sites remote from the inactivating deletion pro-
vides the information necessary for the calculation.
Given this assumption, the following equality holds:
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in which T is the time since the last common ancestor
of human and chimpanzee (approximately 6.6 MYA
[27]), TN is the time since the unitary pseudogene inac-
tivation to be estimated, rS1 = KS1/T is the synonymous
substitution rate in the human lineage,  is the average
KA/KS ratio in all non-human lineages, and KA1 is the
nonsynonymous substitutions per nonsynonymous site
in the human lineage. Rearrange the equation above, we
have:
TT N 




1
1
in which ω1 is the KA/KS ratio in the human lineage.
When only a small number of species are used to esti-
mate TN, its estimated value should be viewed with
caution.
Additional file 1: Supplementary tables. This file contains seven
supplementary tables showing detailed results and datasets used in this
study.
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